Marcel Konrad
Director of Finance/CFO en MEDEXUS PHARMACEUTICALS INC. .
Fortuna: 97 546 $ al 31/03/2024
Perfil
Marcel Konrad is currently the Chief Financial Officer at Medexus Pharmaceuticals, Inc. He previously worked as the Senior VP-Finance, Accounting & Controller at CareDx, Inc. from 2018 to 2021 and as the Chief Financial Officer at Santen, Inc. from 2013 to 2018.
Mr. Konrad holds an MBA from the University of San Diego and an undergraduate degree from École des Hautes Études Commerciales de Paris.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/11/2023 | 80 021 ( 0.33% ) | 97 546 $ | 31/03/2024 |
Cargos activos de Marcel Konrad
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Director of Finance/CFO | 19/07/2021 |
Antiguos cargos conocidos de Marcel Konrad.
| Empresas | Cargo | Fin |
|---|---|---|
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Director of Finance/CFO | 01/07/2018 |
| CAREDX, INC | Director of Finance/CFO | 25/03/2021 |
Formación de Marcel Konrad.
| University of San Diego | Masters Business Admin |
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CAREDX, INC | Health Technology |
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
- Bolsa de valores
- Insiders
- Marcel Konrad
